Nanobiotix S.A. (EPA: NANO)
France flag France · Delayed Price · Currency is EUR
3.066
+0.076 (2.54%)
Dec 27, 2024, 5:35 PM CET

Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of EUR 145.34 million. The enterprise value is 128.18 million.

Market Cap 145.34M
Enterprise Value 128.18M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date Apr 25, 2025
Ex-Dividend Date n/a

Share Statistics

Nanobiotix has 47.40 million shares outstanding. The number of shares has increased by 23.04% in one year.

Current Share Class n/a
Shares Outstanding 47.40M
Shares Change (YoY) +23.04%
Shares Change (QoQ) +21.39%
Owned by Insiders (%) 2.70%
Owned by Institutions (%) 20.49%
Float 25.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.12
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.83
EV / Sales 3.04
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -83.72

Financial Position

The company has a current ratio of 1.42

Current Ratio 1.42
Quick Ratio 1.36
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -32.11
Interest Coverage -2.79

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -22.02%
Return on Capital (ROIC) -101.38%
Revenue Per Employee 383,673
Profits Per Employee -304,300
Employee Count 102
Asset Turnover 0.66
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.30% in the last 52 weeks. The beta is 1.29, so Nanobiotix's price volatility has been higher than the market average.

Beta (5Y) 1.29
52-Week Price Change -48.30%
50-Day Moving Average 3.59
200-Day Moving Average 4.71
Relative Strength Index (RSI) 41.01
Average Volume (20 Days) 145,275

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Nanobiotix had revenue of EUR 42.20 million and -33.47 million in losses. Loss per share was -0.78.

Revenue 42.20M
Gross Profit 42.20M
Operating Income -22.39M
Pretax Income -33.21M
Net Income -33.47M
EBITDA -22.30M
EBIT -22.39M
Loss Per Share -0.78
Full Income Statement

Balance Sheet

The company has 66.34 million in cash and 49.17 million in debt, giving a net cash position of 17.17 million or 0.36 per share.

Cash & Cash Equivalents 66.34M
Total Debt 49.17M
Net Cash 17.17M
Net Cash Per Share 0.36
Equity (Book Value) -21.78M
Book Value Per Share -0.46
Working Capital 23.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.04 million and capital expenditures -494,000, giving a free cash flow of -1.53 million.

Operating Cash Flow -1.04M
Capital Expenditures -494,000
Free Cash Flow -1.53M
FCF Per Share -0.03
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -53.06% and -79.31%.

Gross Margin 100.00%
Operating Margin -53.06%
Pretax Margin -78.69%
Profit Margin -79.31%
EBITDA Margin -52.83%
EBIT Margin -53.06%
FCF Margin n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -23.04%
Shareholder Yield -23.04%
Earnings Yield -25.45%
FCF Yield -1.05%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Nanobiotix has an Altman Z-Score of -3.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.97
Piotroski F-Score n/a